Recent Liver Cancer News

Cabometyx™ May Be ‘New Treatment Option’ for Liver Cancer

(February 20, 2018)

CancerConnect News:  Treatment with Cabometyx  (cabozantinib) significantly improved outcomes in patients with advanced hepatocellular carcinoma (HCC), leading researchers to suggest that it could offer... Continue Reading


Keytruda Immunotherapy Appears Active for Treatment of Liver Cancer

(February 15, 2018)

CancerConnect News:  According to the results of a study presented at the recent gastrointestinal cancer symposia, Keytruda (pembrolizumab) is an active treatment for advanced liver cancer in patients... Continue Reading


Opdivo Precision Cancer Medicine Improves Outcomes in Advanced Liver Cancer

(May 18, 2017)

Results from the CheckMate 040 clinical trial have been recently reported and found that Opdivo (nivolumab), an immuno-oncology drug which acts by modulating the immune system, produces durable responses... Continue Reading


First New Drug for Liver Cancer in a Decade: Stivarga

(May 8, 2017)

The US Food and Drug Administration (FDA) has expanded the indication for Stivarga (regorafenib) to now include treatment for patients with hepatocellular carcinoma (HCC) who have previously been treated... Continue Reading


February: Gallbladder and Bile Duct Awareness Month

(February 18, 2016)

Located underneath the liver, the gallbladder is responsible for the concentration and storage of bile which helps to digest the fats in food as they pass through the intestines. Bile is either released... Continue Reading


Vistogard® Approved for Life-Threatening Toxicities of Certain Chemotherapy Agents

(February 11, 2016)

The United States Food and Drug Administration (FDA) approved Vistogard (uridine triacetate) for the treatment of life-threatening toxicities caused by the chemotherapy drugs fluorouracil or capecitabine. The... Continue Reading


Infection with Hepatitis C Increases Risk of Cirrhosis

(March 10, 2015)

People who are infected with the hepatitis C virus (HCV) have a higher risk for developing the liver disease cirrhosis, particularly within the first five years after infection. These findings were released... Continue Reading


Hepatitis C Cases Could Be Cured By Novel Oral Drug Regimen

(July 31, 2014)

According to the results of two new clinical studies published in The Lancet, two new pill-only antiviral drug regimens for hepatitis C virus infection provide shorter and more effective treatment options... Continue Reading


Liver Cancer Drug Livatag® Granted U.S. Food and Drug Administration Fast Track Designation

(May 27, 2014)

The drug Livatag® (doxorubicin Transdrug™) has received fast-track designation from the U.S. Food and Drug Administration (FDA) for the treatment of primary liver cancer after treatment with Nexavar®... Continue Reading


Coffee Cuts Risk of Liver Cancer

(November 8, 2013)

Good news for coffee addicts—new research has found that regular coffee consumption can reduce the risk of liver cancer by 40 percent. In fact, the study—published in Clinical Gastroenterology and... Continue Reading


Next Page »